BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy
Titel:
BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy
Auteur:
Oing, Christoph Tennstedt, Pierre Simon, Ronald Volquardsen, Jennifer Borgmann, Kerstin Bokemeyer, Carsten Petersen, Cordula Dikomey, Ekkehard Rothkamm, Kai Mansour, Wael Y.